SlideShare une entreprise Scribd logo
1  sur  59
PRESENTED BY
DR. OHIAERI’S UNIT
(TEAM A)
DR. EKE EGHOSASERE PAUL; DR IGBOELI ELOCHUKWU
 Introduction
 Pathogenesis
 Presentation
 Complications
 Diagnosis
 Differential diagnoses
 Investigations
 Management/Treatment
 Conclusion
2/24/2015 2
INTRODUCTION
 Sickle cell disease (SCD) is a potentially devastating
condition that is caused by an autosomal recessive
inherited haemoglobinopathy which results in the
vaso-occlusive phenomena and haemolysis.
 The severity of the complications that occur with this
disorder are widely variable, but overall mortality is
increased and life expectancy decreased when
compared to the general population.
2/24/2015 3
Introduction…
 HbS is a haemoglobin tetramer (α2/βS2) that is poorly
soluble and polymerizes when deoxygenated.
 It is seen worldwide but occurs most frequently in
Africans, and less commonly in those of
Mediterranean and Arab descent. It is also seen in the
Middle East, Southern Europe, some parts of Eastern
Europe and the Indian subcontinent.
2/24/2015 4
Introduction
 1st described in 1910 by Herrick
 SCA denotes the genotype having 2 abnormal Hb both
of which are HbS (i.e. homozygous for HbS)
 SCD denotes all genotypes containing at least one HbS
and another abnormal Hb, in which HbS makes up at
least 50% of the Hb present.
2/24/2015 5
Introduction…
 Inherited as an autosomal recessive (single gene)
disorder
 HbS arises from a mutation substituting thymine for
adenine in the 6th codon of the β-chain gene, GAG to
GTG. This causes coding of valine (fat soluble) instead
of glutamate (water soluble) in position 6 of the Hb β-
chain
2/24/2015 6
Introduction…
 SCD usually manifests early in childhood usually soon
after 6 months of age when HbF levels start to fall
 Epidemiology: In Nigeria, the frequency is 3% of the
general population
 In this centre the total number of patients registered
in the SCA clinic b/w June 2011-January 2013 is 162
patients (age 1-14 yrs)
2/24/2015 7
PATHOGENESIS
 Results from deoxygenation-dependent
polymerization of HbS, with formation of
spindle-shaped liquid crystalline bodies
(tactoids), deforming the RBC , with
increased mechanical fragility and
haemolysis, predominantly at extra-vascular
sites.
2/24/2015 8
Pathogenesis…
 Affected RBCs can undergo repeated cycles
of “sickling and unsickling’’ (when exposed
to low & high O2 levels in the venous &
arterial circulation, respectively)
 Over time some lose the capacity to return
to normal shape →Irreversibly Sickled Cells
(ISC) seen in peripheral blood film
2/24/2015 9
Pathogenesis…
 Factors that promote sickling:
 Often no precipitating cause is found
 Hypoxaemia
 Decreased pH
 Extremes of temperature (fever, cold)
 Advanced cell age
2/24/2015 10
Pathogenesis…
 Increased intracellular HbS
 Dehydration
 Physical Exertion
 Infection
 Hyperleukocytosis
 Low intracellular HbF
 Low 2,3-DPG levels
2/24/2015 11
2/24/2015 12
PRESENTATION
 SCA has a diverse symptomatology
 Any organ or system in the body can be
affected
 Most HbSS patient do not show any sign of
disease in early infancy due to the
predominant presence of HbF
 When HbF levels begin to fall at about age
6mths most patients manifest signs of dx
2/24/2015 13
Presentation…
 6mo to 2yrs
Dactylitis. – due to ischaemic necrosis of
the small bones, believed to be caused by a
choking off of the blood supply as a result of
the rapidly enlarging bone marrow.
Tender,warm,non-pitting swelling of dorsa
of hands and feet.—Hand-foot syndrome.
 Failure to thrive, anaemia, jaundice,
infections, crises.
2/24/2015 14
 Presentation after 2yrs
 Failure to thrive
 Anaemia, jaundice
 Infections
 Crises
 Sickle cell habitus….long, thin limbs,protuberant abd,
gnathopathy, peculiar facies.
2/24/2015 15
Presentation…
 Crises – recurrent episodes of acute illness
experienced by SCA patients
 Steady State – the condition in which the
SCA patient is free of all acute symptoms
and is deemed well
2/24/2015 16
Presentation…
 SCA Crises
 Vaso-occlusive
 Acute anaemic
2/24/2015 17
Presentation…
Vaso-occlusive
 Pain or thrombotic crisis
 Commonest clinical manifestation
 Caused by occlusion of blood vessels
leading to ischaemic injury
 Can affect any part of the body (but
especially the long bones, abdomen,
chest and back)
2/24/2015 18
Presentation…
 About 50% of individuals with SCA
experience VOC
 Frequency of crisis is extremely variable.
Some have up to 6+ episodes/yr. Others may
have episodes only at great intervals or none
at all. But each individual typically has a
consistent pattern for crisis frequency.
 Acute onset and may last several hours to
days and terminate as abruptly as it began.
2/24/2015 19
Presentation…
 Infancy – VOC manifests as hand and foot
syndrome. May present with refusal to walk,
irritability; fever; localized swelling,
tenderness or warmth
 May mimick acute osteomyelitis, septic
arthritis; appendicitis, pancreatitis,
cholecystitis, urinary tract infection, pelvic
inflammatory disease
2/24/2015 20
Presentation…
Acute Anaemic Crises
 Hyperhaemolytic
 Aplastic
 Sequestration
 Megaloblastic
 Iron deficiency
2/24/2015 21
Presentation…
 Hyperhaemolysis – acute exacerbation of the
chronic haemolysis by infectious processes.
Lab shows fall in haematocrit, Hb levels; and
reticulocytosis
 Aplastic – acute failure of erythropoiesis. May
be due to Parvovirus infection; folate
deficiency or severe bone infarction. Lab
shows fall in haemotocrit, Hb; and low or
absent reticulocytes. Usually self-limiting –
bone marrow recovers in 7-10 days
2/24/2015 22
Presentation…
 Sequestration – sudden onset progressive
anaemia, splenomegaly, and signs of
peripheral shock due to trapping of
significant portion of RBC mass in the
spleen.
 Megaloblastic changes – due to higher
folate requirements from the chronic
haemolytic state
2/24/2015 23
Presentation…
Iron deficiency – is uncommon bcos
of increased dietary Fe absorption and
frequent blood transfusions.
May occur as a result of infestations
or poor dietary intake
2/24/2015 24
COMPLICATIONS
 CNS – most severe CNS complication is CVA
(stroke). Others include sensorineural
hearing loss, retinopathy and blindness.
 They may also present with convulsions
 Pulmonary – Acute Chest Syndrome (ACS).
 Is a medical emergency
 Characterized by chest pain, fever, cough,
tachypnoea, prostration, leukocytosis, and
pulmonary infiltrates in the upper lobes.
2/24/2015 25
Complications…
 ACS is usually due to infection. Other
causes: pulmonary infarction, fat
embolism from bone marrow infarction
 Also recurrent sickling episodes in
pulmonary vasculature→formation of
microthrombi→ infarction and damage to
the alveoli. This can result in pulmonary
hypertension
2/24/2015 26
Complications…
 CVS - The heart is affected by the chronic
anemia, and microinfarcts. Haemolysis and
blood transfusion lead to hemosiderin
deposition in the myocardium. Both
ventricles and the left atrium are all dilated
 Liver – 40-80% have hepatomegaly. Usually
due to sinusoidal obstruction (& dilatation)
by sickled RBC, and engorgement of Kupffer
cells ff. phagocytosis of effete RBCs.
 Intrahepatic stasis can result in elevated conj.
bilirubin.
2/24/2015 27
Complications…
 Gallbladder – cholelithiasis; cholecystitis
(Rt upper quadrant pain assoc. with fatty
foods)
 Uncommon in Nigeria due to low fat/high
fibre diet
 Acute cholecystitis may require surgery
 Common bile duct blockage (Rt upper
quadrant pain + elevated conj.
hyperbilirubinaemia)
2/24/2015 28
Complications…
 Spleen
 Splenomegaly in the 1st 2yrs of life due
to extramedullary haemopoiesis,
congestion and sequestration
 Autosplenectomy by 10yrs of age
(especially in temperate regions) as a
result of repeated infarction causing
splenic fibrosis and regression in size
2/24/2015 29
 In Nigeria many SCD children above 10yrs
have splenomegaly probably due to
recurrent malaria infection. However there
is a Functional Asplenia
2/24/2015 30
Complications…
 Immune System
 Impaired immunity & susceptibility to
infections by encapsulated organisms e.g.
H. influenzae, S. pneumoniae. Other
organisms include Salmonella, N.
meningitidis, Mycoplasma, S. aureus, E.
coli and S. pyogenes.
2/24/2015 31
 Underlying factors: Splenic hypofunction,
defective opsonization and abnormal
leukocyte phagocytic action. Recurrent
vaso-occlusion with tissue necrosis, and
elevated serum Fe levels may also be
contributory
2/24/2015 32
Complications…
 Renal:
 Hyposthenuria: inability to concentrate
urine. Presents as polyuria, nocturia and
even enuresis
 Haematuria: from papillary necrosis and
sloughing.
 Nephrotic syndrome has been reported
 CKD is also a common cause of morbidity
& mortality in older patients
2/24/2015 33
Complications…
 UGS:
 Priapism: sustained, painful, and
unwanted erection which may be
spontaneous or follow sexual intercourse
or masturbation.
 Prolonged episodes may lead to impotence
 “Stuttering episodes are managed with oral
stilboestrol while major cases require
sedation and appropriate analgesics
2/24/2015 34
Complications…
 MSS:
 Frontal bossing; gnathopathy (protrusion
of upper teeth; malocclusion)
 Hand/Foot Syndrome (Dactylitis)
 Avascular necrosis of femoral/humeral
head
 Osteomyelitis (frequently Salmonella)
 Leg ulceration (usually affects the
malleolar areas)
2/24/2015 35
Complications…
 Endocrine:
 Delayed physical and sexual development
 Due to chronic anaemia and low
endocrine production
2/24/2015 36
DIAGNOSIS
 Clinical - 80% of cases.
 Screening Tests – indicate presence of HbS
but do not define the Hb genotype e.g.
Solubility test
 4 drops of blood + 2ml of freshly prepared
Na dithionite + K2P04 in a test tube.
 Read against a bright light
 Clear soln…..HbA, CC, DD
 Ppt above, clear soln beneath…….HbSS
 Ppt above, pink soln beneath……HbAS
2/24/2015 37
 Hb Electrophoresis – most common for definitive
diagnosis. Based on differential protein mobility in
an electrical field. Uses cellulose acetate or citrate
agar buffers
2/24/2015 38
 Isoelectric Focusing – also a form of
electrophoresis. Superior to the above.
Method of choice for newborn screening
2/24/2015 39
Diagnosis…
 Prenatal Diagnosis – usually in the first
trimester of pregnancy. Samples are taken
from amniotic cells or chorionic villus and
DNA analysis done by PCR and DNA
sequencing.
2/24/2015 40
LABORATORY FINDINGS
 Full Blood Count
 Increased retic count of 5-15%
 WBC 12-20,000
 Normal MCV
 Hb 5-9g/dl
 Normal or slightly increase platelet count.
 Normal differential or preponderance of
neutrophils
2/24/2015 41
Lab Findings…
 Nucleated RBC indicates severe anaemia
 Target cells, poikilocytosis, anisocytosis,
hypochromic cells, sickled RBC
 Howell-Jolly bodies
 Markedly hyperplastic bone marrow with
erythroid predominance.
2/24/2015 42
DIFFERENTIAL DIAGNOSIS
 1. Leukaemia
 2. Rheumatic fever
 3. Juvenile rheumatoid arthritis
 4. Osteomyelitis
2/24/2015 43
MANAGEMENT
 Early Diagnosis & good follow up
 Determine and record physical,
haematological parameters
 Avoid factors that encourage sickling
 Folic acid supplementation
 Malaria prophylaxis (routine
proguanil)/prevention of other infections
(oral pen V NB-2yrs)
 Immunization: pneumococcal; Hib (@2yrs)
2/24/2015 44
 Health Education & Counselling
2/24/2015 45
Management of Acute Illnesses &
Complications
 Objectives of Mgt
 To relieve pain promptly
 To treat precipitating cause e.g. infection,
dehydration
 To prevent or delay recurrence
 To correct fluid and electrolyte imbalance
 To relieve anxiety
2/24/2015 46
 Management of VOC
Mild to moderate:
 Bed rest at home.
 Liberal oral fluids.
 Analgesics.
 Identify and treat cause.
2/24/2015 47
 Admit
 Administer analgesics commensurate with
degree of pain.
 I.V. fluids are usually given at 1.5x
maintenance
2/24/2015 48
 Management of Hyperhaemolytic crisis
 Admit
 Give O2
 Transfuse in presence of:
1. Anaemic heart failure.
2. PCV below 15%.
3. Significant fall in pcv below steady
state value.
4. Overwhelming infection.
 Diuretics.
2/24/2015 49
 Acute Sequestration Crisis
 Treat shock; elevate foot of bed, give
parenteral steroids (methylpred or
hydroc.)
 Packed cell transfusion, 5-10 ml/kg.
 N.B. Some sequestered cells will return
to the circulation.
 Partial E.B.T.
 Splenectomy
2/24/2015 50
 Aplastic Crisis
 Intermittent oxygen.
 Whole blood transfusions
 Steroid therapy.
 ?Bone marrow transplantation.
2/24/2015 51
 Management of Infections
 Common organisms…….H. infl.,
pneumococcus, salmonella spp., S.
aureus.
 Choice of antibiotics:
 Chloramphenicol + Erythromycin
 Xtalline pen + Chloramphenicol
 Chloramphenicol + Cloxacillin
 Cephalosporins
2/24/2015 52
 Priapism
 Sedatives/anxiolytics.
 Analgesics.
 Intracavernous injection of adrenergic
agonists…e.g. Etilefrine.
 E.B.T
 Surgery, if ICI fails: caverno-spongiosum
anastomosis.
2/24/2015 53
 Haematuria
 Usually stops spontaneously
 Conservative treatment:
 Liberal fluids, to reduce clot formation
 Correct anaemia
 Epsilon amino caproic acid, an
antifibrinolytic agent, is useful in mgt
2/24/2015 54
Other Approaches
 Induction of HbF synthesis
 Hydroxyurea - 15mg/kg/24 hrs. MOA – increases HbF
levels, decreases expression of adhesive molecules on
RBCs and so prevents VOC. Gradually increase to max of
30mg/kg/24hrs. Monitor FBC, LFT and HbF. Increase
in HbF is usually 10-15%
 Recombinant human erythropoietin (rhEPO)
 Resveratrol, a natural dietary polyphenol
 Butyric acid
2/24/2015 55
 Bone Marrow Transplantation
 Has curative potential
 Problems:
1. GVHD
2. Acute effects of total body irradiation
2. Lack of suitable stem cell donors.
3. Limited access to normal HLA
identical
2/24/2015 56
 Stem cell
 Originally, stem cells were procured from
the bone marrow by direct puncture and
aspiration of bone marrow and re-infused
intravenously
 An improvement on bone marrow
transplantation
2/24/2015 57
CONCLUSION
 SCA is a debilitating genetic disease but symptoms can
be alleviated with early diagnosis, and with general
improvement of health status through health
education, regular medical follow up and which can be
prevented with pre-marital counselling.
2/24/2015 58
THANK YOU
2/24/2015 59

Contenu connexe

Tendances

Anemia in children
Anemia in children Anemia in children
Anemia in children Sayed Ahmed
 
Approach to child with generalized body swelling
Approach to child with generalized body swellingApproach to child with generalized body swelling
Approach to child with generalized body swellingElhadi Hajow
 
sickle cell syndrome
sickle cell syndromesickle cell syndrome
sickle cell syndromeSarode Ravi
 
Red Urine and Hematuria in children
Red Urine and Hematuria in childrenRed Urine and Hematuria in children
Red Urine and Hematuria in childrenAzad Haleem
 
Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandipSandip Gupta
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemiaAsif Ahmad
 
NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN Sajjad Sabir
 
Red Cell Physiology & Pathophysiology of Sickle Cell Disease
Red Cell Physiology & Pathophysiology of Sickle Cell DiseaseRed Cell Physiology & Pathophysiology of Sickle Cell Disease
Red Cell Physiology & Pathophysiology of Sickle Cell DiseaseArjuna Samaranayaka
 
Hemophilia (a) - Pediatrics
Hemophilia (a) - PediatricsHemophilia (a) - Pediatrics
Hemophilia (a) - Pediatricspediatricsmgmcri
 
Sickle cell anemia presentation
Sickle cell anemia presentationSickle cell anemia presentation
Sickle cell anemia presentationAdil Khan
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemiaAsif Zeb
 
Approach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in childrenApproach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in childrenSatish Vadapalli
 
Acute Flaccid Paralysis
Acute Flaccid ParalysisAcute Flaccid Paralysis
Acute Flaccid Paralysishanisahwarrior
 
Approach to Anemia
Approach to AnemiaApproach to Anemia
Approach to AnemiaAhmed Azhad
 
Anaemia in children
Anaemia in childrenAnaemia in children
Anaemia in childrengiridharkv
 

Tendances (20)

Anemia in children
Anemia in children Anemia in children
Anemia in children
 
Approach to child with generalized body swelling
Approach to child with generalized body swellingApproach to child with generalized body swelling
Approach to child with generalized body swelling
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
sickle cell syndrome
sickle cell syndromesickle cell syndrome
sickle cell syndrome
 
Red Urine and Hematuria in children
Red Urine and Hematuria in childrenRed Urine and Hematuria in children
Red Urine and Hematuria in children
 
Sickle cell
Sickle cell Sickle cell
Sickle cell
 
Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandip
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Sickle cell anaemia
Sickle cell anaemiaSickle cell anaemia
Sickle cell anaemia
 
NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN
 
Red Cell Physiology & Pathophysiology of Sickle Cell Disease
Red Cell Physiology & Pathophysiology of Sickle Cell DiseaseRed Cell Physiology & Pathophysiology of Sickle Cell Disease
Red Cell Physiology & Pathophysiology of Sickle Cell Disease
 
Fever
FeverFever
Fever
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Hemophilia (a) - Pediatrics
Hemophilia (a) - PediatricsHemophilia (a) - Pediatrics
Hemophilia (a) - Pediatrics
 
Sickle cell anemia presentation
Sickle cell anemia presentationSickle cell anemia presentation
Sickle cell anemia presentation
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Approach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in childrenApproach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in children
 
Acute Flaccid Paralysis
Acute Flaccid ParalysisAcute Flaccid Paralysis
Acute Flaccid Paralysis
 
Approach to Anemia
Approach to AnemiaApproach to Anemia
Approach to Anemia
 
Anaemia in children
Anaemia in childrenAnaemia in children
Anaemia in children
 

Similaire à SICKLE CELL ANAEMIA

Ppt Presentation For Pac 5110
Ppt Presentation For Pac 5110Ppt Presentation For Pac 5110
Ppt Presentation For Pac 5110pjaffey
 
SICKLE CELL DISORDER BY DR. BABU.pptx
SICKLE CELL DISORDER BY DR. BABU.pptxSICKLE CELL DISORDER BY DR. BABU.pptx
SICKLE CELL DISORDER BY DR. BABU.pptxAugustusCaesar7
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndromeAhmed Zuhry
 
pediatrics 6. Sickle Cell Anemia 6.1.pptx
pediatrics 6. Sickle Cell Anemia 6.1.pptxpediatrics 6. Sickle Cell Anemia 6.1.pptx
pediatrics 6. Sickle Cell Anemia 6.1.pptxArun170190
 
SICKELE CELL DISEASE MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
SICKELE CELL DISEASE   MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptxSICKELE CELL DISEASE   MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
SICKELE CELL DISEASE MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptxSEJOJO PHAAROE
 
Kawasaki disease
Kawasaki diseaseKawasaki disease
Kawasaki diseaseAhmed Ahmed
 
Haemoglobinopathies npmc.ppt
Haemoglobinopathies npmc.pptHaemoglobinopathies npmc.ppt
Haemoglobinopathies npmc.pptKemi Adaramola
 
Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)Manjit Tendolkar
 
Sickle cell diseases & Beyond.pptx
Sickle cell diseases & Beyond.pptxSickle cell diseases & Beyond.pptx
Sickle cell diseases & Beyond.pptxMudreka3
 
Hematology oncology-nurs 3340
Hematology oncology-nurs 3340Hematology oncology-nurs 3340
Hematology oncology-nurs 3340Shepard Joy
 
Lecture 7 (SCD New) 2.pptx
Lecture 7 (SCD New) 2.pptxLecture 7 (SCD New) 2.pptx
Lecture 7 (SCD New) 2.pptxHappychifunda
 
All ACUTE LYMPHOBLASTIC LEUKEMIA BY DR MAGDI SASI
All ACUTE LYMPHOBLASTIC LEUKEMIA  BY DR MAGDI SASIAll ACUTE LYMPHOBLASTIC LEUKEMIA  BY DR MAGDI SASI
All ACUTE LYMPHOBLASTIC LEUKEMIA BY DR MAGDI SASIcardilogy
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell diseaseIjeh Cyril
 
Unit 5 Sickle cell-3.pdf
Unit 5 Sickle cell-3.pdfUnit 5 Sickle cell-3.pdf
Unit 5 Sickle cell-3.pdfJohnmvula3
 

Similaire à SICKLE CELL ANAEMIA (20)

Ppt Presentation For Pac 5110
Ppt Presentation For Pac 5110Ppt Presentation For Pac 5110
Ppt Presentation For Pac 5110
 
SICKLE CELL DISORDER BY DR. BABU.pptx
SICKLE CELL DISORDER BY DR. BABU.pptxSICKLE CELL DISORDER BY DR. BABU.pptx
SICKLE CELL DISORDER BY DR. BABU.pptx
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndrome
 
HUS
HUSHUS
HUS
 
pediatrics 6. Sickle Cell Anemia 6.1.pptx
pediatrics 6. Sickle Cell Anemia 6.1.pptxpediatrics 6. Sickle Cell Anemia 6.1.pptx
pediatrics 6. Sickle Cell Anemia 6.1.pptx
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
Lupus overview for journalist
Lupus overview for journalistLupus overview for journalist
Lupus overview for journalist
 
SICKELE CELL DISEASE MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
SICKELE CELL DISEASE   MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptxSICKELE CELL DISEASE   MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
SICKELE CELL DISEASE MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
 
Kawasaki disease
Kawasaki diseaseKawasaki disease
Kawasaki disease
 
Haemoglobinopathies npmc.ppt
Haemoglobinopathies npmc.pptHaemoglobinopathies npmc.ppt
Haemoglobinopathies npmc.ppt
 
Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)
 
Sickle cell diseases & Beyond.pptx
Sickle cell diseases & Beyond.pptxSickle cell diseases & Beyond.pptx
Sickle cell diseases & Beyond.pptx
 
Hematology oncology-nurs 3340
Hematology oncology-nurs 3340Hematology oncology-nurs 3340
Hematology oncology-nurs 3340
 
Lecture 7 (SCD New) 2.pptx
Lecture 7 (SCD New) 2.pptxLecture 7 (SCD New) 2.pptx
Lecture 7 (SCD New) 2.pptx
 
All ACUTE LYMPHOBLASTIC LEUKEMIA BY DR MAGDI SASI
All ACUTE LYMPHOBLASTIC LEUKEMIA  BY DR MAGDI SASIAll ACUTE LYMPHOBLASTIC LEUKEMIA  BY DR MAGDI SASI
All ACUTE LYMPHOBLASTIC LEUKEMIA BY DR MAGDI SASI
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
Leukomias.pptx
Leukomias.pptxLeukomias.pptx
Leukomias.pptx
 
Unit 5 Sickle cell-3.pdf
Unit 5 Sickle cell-3.pdfUnit 5 Sickle cell-3.pdf
Unit 5 Sickle cell-3.pdf
 

SICKLE CELL ANAEMIA

  • 1. PRESENTED BY DR. OHIAERI’S UNIT (TEAM A) DR. EKE EGHOSASERE PAUL; DR IGBOELI ELOCHUKWU
  • 2.  Introduction  Pathogenesis  Presentation  Complications  Diagnosis  Differential diagnoses  Investigations  Management/Treatment  Conclusion 2/24/2015 2
  • 3. INTRODUCTION  Sickle cell disease (SCD) is a potentially devastating condition that is caused by an autosomal recessive inherited haemoglobinopathy which results in the vaso-occlusive phenomena and haemolysis.  The severity of the complications that occur with this disorder are widely variable, but overall mortality is increased and life expectancy decreased when compared to the general population. 2/24/2015 3
  • 4. Introduction…  HbS is a haemoglobin tetramer (α2/βS2) that is poorly soluble and polymerizes when deoxygenated.  It is seen worldwide but occurs most frequently in Africans, and less commonly in those of Mediterranean and Arab descent. It is also seen in the Middle East, Southern Europe, some parts of Eastern Europe and the Indian subcontinent. 2/24/2015 4
  • 5. Introduction  1st described in 1910 by Herrick  SCA denotes the genotype having 2 abnormal Hb both of which are HbS (i.e. homozygous for HbS)  SCD denotes all genotypes containing at least one HbS and another abnormal Hb, in which HbS makes up at least 50% of the Hb present. 2/24/2015 5
  • 6. Introduction…  Inherited as an autosomal recessive (single gene) disorder  HbS arises from a mutation substituting thymine for adenine in the 6th codon of the β-chain gene, GAG to GTG. This causes coding of valine (fat soluble) instead of glutamate (water soluble) in position 6 of the Hb β- chain 2/24/2015 6
  • 7. Introduction…  SCD usually manifests early in childhood usually soon after 6 months of age when HbF levels start to fall  Epidemiology: In Nigeria, the frequency is 3% of the general population  In this centre the total number of patients registered in the SCA clinic b/w June 2011-January 2013 is 162 patients (age 1-14 yrs) 2/24/2015 7
  • 8. PATHOGENESIS  Results from deoxygenation-dependent polymerization of HbS, with formation of spindle-shaped liquid crystalline bodies (tactoids), deforming the RBC , with increased mechanical fragility and haemolysis, predominantly at extra-vascular sites. 2/24/2015 8
  • 9. Pathogenesis…  Affected RBCs can undergo repeated cycles of “sickling and unsickling’’ (when exposed to low & high O2 levels in the venous & arterial circulation, respectively)  Over time some lose the capacity to return to normal shape →Irreversibly Sickled Cells (ISC) seen in peripheral blood film 2/24/2015 9
  • 10. Pathogenesis…  Factors that promote sickling:  Often no precipitating cause is found  Hypoxaemia  Decreased pH  Extremes of temperature (fever, cold)  Advanced cell age 2/24/2015 10
  • 11. Pathogenesis…  Increased intracellular HbS  Dehydration  Physical Exertion  Infection  Hyperleukocytosis  Low intracellular HbF  Low 2,3-DPG levels 2/24/2015 11
  • 13. PRESENTATION  SCA has a diverse symptomatology  Any organ or system in the body can be affected  Most HbSS patient do not show any sign of disease in early infancy due to the predominant presence of HbF  When HbF levels begin to fall at about age 6mths most patients manifest signs of dx 2/24/2015 13
  • 14. Presentation…  6mo to 2yrs Dactylitis. – due to ischaemic necrosis of the small bones, believed to be caused by a choking off of the blood supply as a result of the rapidly enlarging bone marrow. Tender,warm,non-pitting swelling of dorsa of hands and feet.—Hand-foot syndrome.  Failure to thrive, anaemia, jaundice, infections, crises. 2/24/2015 14
  • 15.  Presentation after 2yrs  Failure to thrive  Anaemia, jaundice  Infections  Crises  Sickle cell habitus….long, thin limbs,protuberant abd, gnathopathy, peculiar facies. 2/24/2015 15
  • 16. Presentation…  Crises – recurrent episodes of acute illness experienced by SCA patients  Steady State – the condition in which the SCA patient is free of all acute symptoms and is deemed well 2/24/2015 16
  • 17. Presentation…  SCA Crises  Vaso-occlusive  Acute anaemic 2/24/2015 17
  • 18. Presentation… Vaso-occlusive  Pain or thrombotic crisis  Commonest clinical manifestation  Caused by occlusion of blood vessels leading to ischaemic injury  Can affect any part of the body (but especially the long bones, abdomen, chest and back) 2/24/2015 18
  • 19. Presentation…  About 50% of individuals with SCA experience VOC  Frequency of crisis is extremely variable. Some have up to 6+ episodes/yr. Others may have episodes only at great intervals or none at all. But each individual typically has a consistent pattern for crisis frequency.  Acute onset and may last several hours to days and terminate as abruptly as it began. 2/24/2015 19
  • 20. Presentation…  Infancy – VOC manifests as hand and foot syndrome. May present with refusal to walk, irritability; fever; localized swelling, tenderness or warmth  May mimick acute osteomyelitis, septic arthritis; appendicitis, pancreatitis, cholecystitis, urinary tract infection, pelvic inflammatory disease 2/24/2015 20
  • 21. Presentation… Acute Anaemic Crises  Hyperhaemolytic  Aplastic  Sequestration  Megaloblastic  Iron deficiency 2/24/2015 21
  • 22. Presentation…  Hyperhaemolysis – acute exacerbation of the chronic haemolysis by infectious processes. Lab shows fall in haematocrit, Hb levels; and reticulocytosis  Aplastic – acute failure of erythropoiesis. May be due to Parvovirus infection; folate deficiency or severe bone infarction. Lab shows fall in haemotocrit, Hb; and low or absent reticulocytes. Usually self-limiting – bone marrow recovers in 7-10 days 2/24/2015 22
  • 23. Presentation…  Sequestration – sudden onset progressive anaemia, splenomegaly, and signs of peripheral shock due to trapping of significant portion of RBC mass in the spleen.  Megaloblastic changes – due to higher folate requirements from the chronic haemolytic state 2/24/2015 23
  • 24. Presentation… Iron deficiency – is uncommon bcos of increased dietary Fe absorption and frequent blood transfusions. May occur as a result of infestations or poor dietary intake 2/24/2015 24
  • 25. COMPLICATIONS  CNS – most severe CNS complication is CVA (stroke). Others include sensorineural hearing loss, retinopathy and blindness.  They may also present with convulsions  Pulmonary – Acute Chest Syndrome (ACS).  Is a medical emergency  Characterized by chest pain, fever, cough, tachypnoea, prostration, leukocytosis, and pulmonary infiltrates in the upper lobes. 2/24/2015 25
  • 26. Complications…  ACS is usually due to infection. Other causes: pulmonary infarction, fat embolism from bone marrow infarction  Also recurrent sickling episodes in pulmonary vasculature→formation of microthrombi→ infarction and damage to the alveoli. This can result in pulmonary hypertension 2/24/2015 26
  • 27. Complications…  CVS - The heart is affected by the chronic anemia, and microinfarcts. Haemolysis and blood transfusion lead to hemosiderin deposition in the myocardium. Both ventricles and the left atrium are all dilated  Liver – 40-80% have hepatomegaly. Usually due to sinusoidal obstruction (& dilatation) by sickled RBC, and engorgement of Kupffer cells ff. phagocytosis of effete RBCs.  Intrahepatic stasis can result in elevated conj. bilirubin. 2/24/2015 27
  • 28. Complications…  Gallbladder – cholelithiasis; cholecystitis (Rt upper quadrant pain assoc. with fatty foods)  Uncommon in Nigeria due to low fat/high fibre diet  Acute cholecystitis may require surgery  Common bile duct blockage (Rt upper quadrant pain + elevated conj. hyperbilirubinaemia) 2/24/2015 28
  • 29. Complications…  Spleen  Splenomegaly in the 1st 2yrs of life due to extramedullary haemopoiesis, congestion and sequestration  Autosplenectomy by 10yrs of age (especially in temperate regions) as a result of repeated infarction causing splenic fibrosis and regression in size 2/24/2015 29
  • 30.  In Nigeria many SCD children above 10yrs have splenomegaly probably due to recurrent malaria infection. However there is a Functional Asplenia 2/24/2015 30
  • 31. Complications…  Immune System  Impaired immunity & susceptibility to infections by encapsulated organisms e.g. H. influenzae, S. pneumoniae. Other organisms include Salmonella, N. meningitidis, Mycoplasma, S. aureus, E. coli and S. pyogenes. 2/24/2015 31
  • 32.  Underlying factors: Splenic hypofunction, defective opsonization and abnormal leukocyte phagocytic action. Recurrent vaso-occlusion with tissue necrosis, and elevated serum Fe levels may also be contributory 2/24/2015 32
  • 33. Complications…  Renal:  Hyposthenuria: inability to concentrate urine. Presents as polyuria, nocturia and even enuresis  Haematuria: from papillary necrosis and sloughing.  Nephrotic syndrome has been reported  CKD is also a common cause of morbidity & mortality in older patients 2/24/2015 33
  • 34. Complications…  UGS:  Priapism: sustained, painful, and unwanted erection which may be spontaneous or follow sexual intercourse or masturbation.  Prolonged episodes may lead to impotence  “Stuttering episodes are managed with oral stilboestrol while major cases require sedation and appropriate analgesics 2/24/2015 34
  • 35. Complications…  MSS:  Frontal bossing; gnathopathy (protrusion of upper teeth; malocclusion)  Hand/Foot Syndrome (Dactylitis)  Avascular necrosis of femoral/humeral head  Osteomyelitis (frequently Salmonella)  Leg ulceration (usually affects the malleolar areas) 2/24/2015 35
  • 36. Complications…  Endocrine:  Delayed physical and sexual development  Due to chronic anaemia and low endocrine production 2/24/2015 36
  • 37. DIAGNOSIS  Clinical - 80% of cases.  Screening Tests – indicate presence of HbS but do not define the Hb genotype e.g. Solubility test  4 drops of blood + 2ml of freshly prepared Na dithionite + K2P04 in a test tube.  Read against a bright light  Clear soln…..HbA, CC, DD  Ppt above, clear soln beneath…….HbSS  Ppt above, pink soln beneath……HbAS 2/24/2015 37
  • 38.  Hb Electrophoresis – most common for definitive diagnosis. Based on differential protein mobility in an electrical field. Uses cellulose acetate or citrate agar buffers 2/24/2015 38
  • 39.  Isoelectric Focusing – also a form of electrophoresis. Superior to the above. Method of choice for newborn screening 2/24/2015 39
  • 40. Diagnosis…  Prenatal Diagnosis – usually in the first trimester of pregnancy. Samples are taken from amniotic cells or chorionic villus and DNA analysis done by PCR and DNA sequencing. 2/24/2015 40
  • 41. LABORATORY FINDINGS  Full Blood Count  Increased retic count of 5-15%  WBC 12-20,000  Normal MCV  Hb 5-9g/dl  Normal or slightly increase platelet count.  Normal differential or preponderance of neutrophils 2/24/2015 41
  • 42. Lab Findings…  Nucleated RBC indicates severe anaemia  Target cells, poikilocytosis, anisocytosis, hypochromic cells, sickled RBC  Howell-Jolly bodies  Markedly hyperplastic bone marrow with erythroid predominance. 2/24/2015 42
  • 43. DIFFERENTIAL DIAGNOSIS  1. Leukaemia  2. Rheumatic fever  3. Juvenile rheumatoid arthritis  4. Osteomyelitis 2/24/2015 43
  • 44. MANAGEMENT  Early Diagnosis & good follow up  Determine and record physical, haematological parameters  Avoid factors that encourage sickling  Folic acid supplementation  Malaria prophylaxis (routine proguanil)/prevention of other infections (oral pen V NB-2yrs)  Immunization: pneumococcal; Hib (@2yrs) 2/24/2015 44
  • 45.  Health Education & Counselling 2/24/2015 45
  • 46. Management of Acute Illnesses & Complications  Objectives of Mgt  To relieve pain promptly  To treat precipitating cause e.g. infection, dehydration  To prevent or delay recurrence  To correct fluid and electrolyte imbalance  To relieve anxiety 2/24/2015 46
  • 47.  Management of VOC Mild to moderate:  Bed rest at home.  Liberal oral fluids.  Analgesics.  Identify and treat cause. 2/24/2015 47
  • 48.  Admit  Administer analgesics commensurate with degree of pain.  I.V. fluids are usually given at 1.5x maintenance 2/24/2015 48
  • 49.  Management of Hyperhaemolytic crisis  Admit  Give O2  Transfuse in presence of: 1. Anaemic heart failure. 2. PCV below 15%. 3. Significant fall in pcv below steady state value. 4. Overwhelming infection.  Diuretics. 2/24/2015 49
  • 50.  Acute Sequestration Crisis  Treat shock; elevate foot of bed, give parenteral steroids (methylpred or hydroc.)  Packed cell transfusion, 5-10 ml/kg.  N.B. Some sequestered cells will return to the circulation.  Partial E.B.T.  Splenectomy 2/24/2015 50
  • 51.  Aplastic Crisis  Intermittent oxygen.  Whole blood transfusions  Steroid therapy.  ?Bone marrow transplantation. 2/24/2015 51
  • 52.  Management of Infections  Common organisms…….H. infl., pneumococcus, salmonella spp., S. aureus.  Choice of antibiotics:  Chloramphenicol + Erythromycin  Xtalline pen + Chloramphenicol  Chloramphenicol + Cloxacillin  Cephalosporins 2/24/2015 52
  • 53.  Priapism  Sedatives/anxiolytics.  Analgesics.  Intracavernous injection of adrenergic agonists…e.g. Etilefrine.  E.B.T  Surgery, if ICI fails: caverno-spongiosum anastomosis. 2/24/2015 53
  • 54.  Haematuria  Usually stops spontaneously  Conservative treatment:  Liberal fluids, to reduce clot formation  Correct anaemia  Epsilon amino caproic acid, an antifibrinolytic agent, is useful in mgt 2/24/2015 54
  • 55. Other Approaches  Induction of HbF synthesis  Hydroxyurea - 15mg/kg/24 hrs. MOA – increases HbF levels, decreases expression of adhesive molecules on RBCs and so prevents VOC. Gradually increase to max of 30mg/kg/24hrs. Monitor FBC, LFT and HbF. Increase in HbF is usually 10-15%  Recombinant human erythropoietin (rhEPO)  Resveratrol, a natural dietary polyphenol  Butyric acid 2/24/2015 55
  • 56.  Bone Marrow Transplantation  Has curative potential  Problems: 1. GVHD 2. Acute effects of total body irradiation 2. Lack of suitable stem cell donors. 3. Limited access to normal HLA identical 2/24/2015 56
  • 57.  Stem cell  Originally, stem cells were procured from the bone marrow by direct puncture and aspiration of bone marrow and re-infused intravenously  An improvement on bone marrow transplantation 2/24/2015 57
  • 58. CONCLUSION  SCA is a debilitating genetic disease but symptoms can be alleviated with early diagnosis, and with general improvement of health status through health education, regular medical follow up and which can be prevented with pre-marital counselling. 2/24/2015 58